Delivery of the photosensitizer Pc 4 in PEG - PCL micelles for in vitro PDT studies

Journal of Pharmaceutical Sciences

Volumn 99, Issue 5, 2010, Pages 2386-2398

  Master, Alyssa M ^a   Rodriguez, Myriam E ^b   Kenney, Malcolm E ^c   Oleinick, Nancy L ^b,c   Gupta, Anirban Sen ^a,c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Biocompatibility; Cancer; Controlled delivery; Formulation; Micelle; Nanoparticles; Polymeric drug delivery systems

Indexed keywords

COPOLYMER; PC 4; PHOTOSENSITIZING AGENT; POLYETHYLENE GLYCOL BLOCK POLY EPSILON CAPROLACTONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CELL DEATH; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO CULTURE; INFRARED SPECTROSCOPY; MICELLE; NANOMEDICINE; NUCLEAR MAGNETIC RESONANCE; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; QUANTITATIVE ANALYSIS; RING OPENING; SYNTHESIS; TUMOR MODEL;

EID: 77951259931     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22007     Document Type: Article

References (49)

1. Wang KK, Wilson JD, Kenney ME, Mitra S, Foster TH. 2007. Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT. Photochem Photobiol 83:1056-1062. (Pubitemid 47438513)
2. Stewart BW, Kleihues P. 2003. World Cancer Report. IARC Press, Lyon, France World Health Organization IARC.
3. Triesscheijn M, Baas P, Schellens JH, Stewart FA. 2006. Photodynamic therapy in oncology. Oncologist 11:1034-1044.
4. Foote CS. 1991. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 54:659.
5. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. 1975. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 55:115-121.
6. Rodriguez ME, Awruch J, Dicelio L. 2002. Photophysical properties of Zn(II) phthalocyaninates incorporated into liposomes. J Porphyrins Phthalocyanines 6:122-129.
7. Ichikawa K, Hikita T, Maeda N, Yonezawa S, Takeuchi Y, Asai T, Namba Y, Oku N. 2005. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim Biophys Acta 1669:69-74. (Pubitemid 40544523)
8. Derycke AS, de Witte PA. 2004. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 56:17-30.
9. Chen B, Pogue BW, Hasan T. 2005. Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv 2:477-487.
10. Zhang GD, Harada A, Nishiyama N, Jiang DL, Koyama H, Aida T, Kataoka K. 2003. Polyion complex micelles entrapping cationic dendrimer porphyrin: Effective photosensitizer for photodynamic therapy of cancer. J Control Release 93:141-150. (Pubitemid 37421356)
11. Jang WD, Nakagishi Y, Nishiyama N, Kawauchi S, Morimoto Y, Kikuchi M, Kataoka K. 2006. Polyion complex micelles for photodynamic therapy: Incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissuepenetrating property. J Control Release 113:73-79. (Pubitemid 43818161)
12. Zhang JX, Hansen CB, Allen TM, Boey A, Boch R. 2003. Lipidderivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivatives. J Control Release 86:323-338. (Pubitemid 36090117)
13. van Nostrum CF. 2004. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 56:9-16. (Pubitemid 38045421)
14. Sibata MN, Tedesco AC, Marchetti JM. 2004. Photophysicals and photochemicals studies of zinc(II) phthalocyanine in long time circulation micelles for photodynamic therapy use. Eur J Pharm Sci 23:131-138.
15. Rodriguez ME, Fernandez DA, Awruch J, Braslavsky SE, Dicelio LE. 2006. Effect of aggregation of a cationic phthalocyanine in micelles and in the presence of human serum albumin. J Porphyrins Phthalocyanines 10:33-42.
16. Tang W, Xu H, Kopelman R, Philbert MA. 2005. Photodynamic characterization and in vitro application of methylene bluecontaining nanoparticle platforms. Photochem Photobiol 81:242-249. (Pubitemid 40551499)
17. Sharman WM, van Lier JE, Allen CM. 2004. Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Deliv Rev 56:53-76.
18. Ricci-Junior E, Marchetti JM. 2006. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J Microencapsul 23:523-538. (Pubitemid 44446594)
19. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. 2003. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 84:4023-4032. (Pubitemid 36637894)
20. Kopelman RKY, Philbert M, Moffat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Bhojani MS, Buck CM, Rehemtulla A, Ross BD. 2005. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J Magn Magn Mater 293:404-410. (Pubitemid 40608959)
21. Konan YN, Berton M, Gurny R, Allemann E. 2003. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200nm nanoparticles. Eur J Pharm Sci 18:241-249. (Pubitemid 36349275)
22. Cheng YACS, Meyers JD, Panagopoulos I, Fei B, Burda C. 2008. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 130:10643-10647.
23. Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell DA. 2006. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: Cancer therapy using a 'Trojan horse'. Photochem Photobiol Sci 5:727-734.
24. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. 2003. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125:7860-7865. (Pubitemid 36782161)
25. Gu H, Xu K, Yang Z, Chang CK, Xu B. 2005. Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. Chem Commun (Camb) (34):4270-4272. (Pubitemid 41345332)
26. Chen W, Zhang J. 2006. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol 6:1159-1166. (Pubitemid 44578047)
27. Hamblin MR, Miller JL, Ortel B. 2000. Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol 72:533-540.
28. Rosenkranz AA, Jans DA, Sobolev AS. 2000. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol 78:452-464.
29. Derycke AS, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, Huwyler J, Missiaen L, de Witte PA. 2004. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst 96:1620-1630. (Pubitemid 39534886)
30. Anderson CY, Freye K, Tubesing KA, Li YS, Kenney ME, Mukhtar H, Elmets CA. 1998. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochem Photobiol 67:332-336. (Pubitemid 128472248)
31. Oleinick NL, Morris RL, Belichenko I. 2002. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem Photobiol Sci 1:1-21. (Pubitemid 37069701)
32. Oleinick NL, Antunez AR, Clay ME, Rihter BD, Kenney ME. 1993. New phthalocyanine photosensitizers for photodynamic therapy. Photochem Photobiol 57:242-247.
33. Colussi VC, Feyes DK, Mulvihill JW, Li YS, Kenney ME, Elmets CA, Oleinick NL, Mukhtar H. 1999. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol 69:236-241. (Pubitemid 129606912)
34. Savic R, Luo L, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618. (Pubitemid 36520581)
35. Rodriguez ME, Zhang P, Azizuddin K, Delos Santos GB, Chiu SM, Xue LY, Berlin JC, Peng X, Wu H, Lam M, Nieminen AL, Kenney ME, Oleinick NL. 2009. Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria. Photochem Photobiol 85:1189-1200.
36. He J, Larkin HE, Li YS, Rihter D, Zaidi SI, Rodgers MA, Mukhtar H, Kenney ME, Oleinick NL. 1997. The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol 65:581-586. (Pubitemid 27159001)
37. Biolo R, Jori G, Soncin M, Rihter B, Kenney ME, Rodgers MA. 1996. Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice. Photochem Photobiol 63:224-228. (Pubitemid 2617486)
38. Xue LY, Chiu SM, Oleinick NL. 2001. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: A role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp Cell Res 263:145-155.
39. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL. 2007. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 224:290-299. (Pubitemid 47575679)
40. Walderhaug H, Söderman O. 2009. NMR studies of block copolymer micelles. Curr Opin Colloid Interf Sci 14:171-177.
41. Remant Bahadur KC, Bhattarai SR, Aryal S, Khil MS, Dharmaraj N, Kim HY. 2007. Novel amphiphilic triblock copolymer based on PPDO, PCL, and PEG: Synthesis, characterization, and aqueous dispersion. Colloids Surf A: Physicochem Eng Aspects 292:69-78. (Pubitemid 44920362)
42. Choi C, Su Young C, Kim T, Jang M, Chong SC, Nah J. 2005. Preparation and characterizations of poly(ethylene glycol)-poly(e-caprolactone) block copolymer nanoparticles. Bull Korean Chem Soc 26:523. (Pubitemid 40688073)
43. Si ZH, Wang GC, Li HX, Yuan JL, He BL. 2003. Studies on micellization of a polystyrene-b-poly(acrylic acid) copolymer in aqueous media by pyrene fluorescence. Chin Chem Lett 14: 39 33-41.
44. Letchford K, Liggins R, Burt H. 2008. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: Theoretical and experimental data and correlations. J Pharm Sci 97:1179-1190.
45. Soo PL, Luo L, Maysinger D, Eisenberg A. 2002. Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly(ethylene oxide) micelles: Implications for drug delivery. Langmuir 18:9996-10004.
46. Gan Z, Jim TF, Li M, Yuer Z, Wang S, Wu C. 1999. Enzymatic biodegradation of poly(ethylene oxide-b-caprolactone) diblock copolymer and its potential biomedical applications. Macromolecules 32:590-594.
47. Zavodnik IB, Zavodnik LB, Bryszewska MJ. 2002. The mechanism of Zn-phthalocyanine photosensitized lysis of human erythrocytes. J Photochem Photobiol B 67:1-10.
48. Kataoka K, Harada A, Nagasaki Y. 2001. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 47:113-131. (Pubitemid 32209236)
49. Rijcken CJ, Hofman JW, van Zeeland F, Hennink WE, van Nostrum CF. 2007. Photosensitiser-loaded biodegradable polymeric micelles: Preparation, characterisation and in vitro PDT efficacy. J Control Release 124:144-153. (Pubitemid 350101885)